Bone mineral density and risk of breast cancer in postmenopausal women (Q43954762)

28 November 2017

0 references

Bone mineral density and risk of breast cancer in postmenopausal women (English)

1 reference

28 November 2017

1 reference

28 November 2017

Kerong Dai

1 reference

28 November 2017

Zanjing Zhai

1 reference

28 November 2017

Guangwang Liu

1 reference

28 November 2017

Xiaoyu Zhang

1 reference

28 November 2017

An Qin

1 reference

28 November 2017

Yongqiang Hao

1 reference

28 November 2017

Huiwu Li

1 reference

28 November 2017

Zhenan Zhu

1 reference

28 November 2017

language of work or name

English

0 references

publication date

5 February 2013

1 reference

Breast Cancer Research and Treatment

28 November 2017

published in

1 reference

28 November 2017

volume

138

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

261-271

1 reference

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Are breast density and bone mineral density independent risk factors for breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bone mass and breast cancer risk in older women: differences by stage at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bone mineral density and prediction of non-osteoporotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bone mineral density and breast cancer risk in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bone mineral density and the risk of breast cancer: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bone mass density and risk of breast cancer and survival in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Risk factors for breast cancer and expression of insulin-like growth factor-2 (IGF-2) in women with breast cancer in Wuhan City, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Bone mineral density and risk of postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2431-3

10.1007/S10549-013-2431-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1037905155

0 references

1 reference